NCT02172222View on ClinicalTrials.gov

Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

September 30, 2009

Conditions
Healthy
Interventions
DRUG

BI 10773

DRUG

Linagliptin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY